88323 CPT® code: payer coverage and prior authorization88323 appears in 6 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross NC, BlueCross BlueShield of South Carolina, Cigna.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Genetic Testing (0140) Genetic testing for dominant polycystic kidney disease (PKD1 and PKD2) | covered if criteria are met | Aug 18, 2026 | payer document |
| Aetna | Tumor Markers (0352) | listed, no stance | Aug 25, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Systems Pathology In Prostate Cancer (L.2.04.429) | unproven / investigational | payer document | |
| Blue Cross NC | Professional Pathology Billing Requirements AHS – R2169 | listed, no stance (range 88300-88399) | Mar 1, 2024 | payer document |
| BlueCross BlueShield of South Carolina | Laboratory/Pathology Services (CAM 472) | listed, no stance | Jan 1, 2026 | payer document |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.